GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioTech Medics Inc (OTCPK:BMCS) » Definitions » Gross Profit

BioTech Medics (BioTech Medics) Gross Profit : $0.00 Mil (TTM As of . 20)


View and export this data going back to . Start your Free Trial

What is BioTech Medics Gross Profit?

BioTech Medics's gross profit for the three months ended in . 20 was $0.00 Mil. BioTech Medics's gross profit for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. BioTech Medics's gross profit for the three months ended in . 20 was $0.00 Mil. BioTech Medics's Revenue for the three months ended in . 20 was $0.00 Mil. Therefore, BioTech Medics's Gross Margin % for the quarter that ended in . 20 was N/A%.

BioTech Medics had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


BioTech Medics Gross Profit Historical Data

The historical data trend for BioTech Medics's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioTech Medics Gross Profit Chart

BioTech Medics Annual Data
Trend
Gross Profit

BioTech Medics Quarterly Data
Gross Profit

Competitive Comparison of BioTech Medics's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, BioTech Medics's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioTech Medics's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, BioTech Medics's Gross Profit distribution charts can be found below:

* The bar in red indicates where BioTech Medics's Gross Profit falls into.



BioTech Medics Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

BioTech Medics's Gross Profit for the fiscal year that ended in . 20 is calculated as

Gross Profit (A: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

BioTech Medics's Gross Profit for the quarter that ended in . 20 is calculated as

Gross Profit (Q: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Gross Profit for the trailing twelve months (TTM) ended in . 20 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

BioTech Medics's Gross Margin % for the quarter that ended in . 20 is calculated as

Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


BioTech Medics  (OTCPK:BMCS) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

BioTech Medics had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


BioTech Medics Gross Profit Related Terms

Thank you for viewing the detailed overview of BioTech Medics's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


BioTech Medics (BioTech Medics) Business Description

Traded in Other Exchanges
N/A
Address
5850 Canoga Avenue, Suite 400, Woodland Hills, Los Angeles, CA, USA, 91367
BioTech Medics Inc is a medical-based holding company. The company operates through four divisions namely Medical, Nutraceutical Products, Sports Medicine, and Research and Development.